Sio Capital Management, LLC 13F 持仓 · 2026年Q2
Sio Capital Management 在 2026年Q2（报告期截至 2026-06-30）的 SEC 13F 申报中报告了 57 只证券，申报市值合计 6.04 亿美元。前几大持仓：AVR（9.04%）、COR（8.13%）、MMS（6.36%）。本季前 25 大持仓中：新建仓 9 只、增持 8 只、减持 7 只。
| 排名 | 代码 | 公司 | 市值 | 占组合 | 股数 | 变动 |
|---|---|---|---|---|---|---|
| 1 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $54.6M | 9.04% | 5.5M | 增持 |
| 2 | COR | CENCORA INC | $49.1M | 8.13% | 173,588 | 增持 |
| 3 | MMS | MAXIMUS INC | $38.5M | 6.36% | 715,267 | 减持 |
| 4 | ALLO | ALLOGENE THERAPEUTICS INC | $27.7M | 4.59% | 13.3M | 新建仓 |
| 5 | GMED | GLOBUS MED INC | $23.8M | 3.95% | 301,816 | 新建仓 |
| 6 | GSK | GSK PLC | $22.9M | 3.79% | 436,700 | 增持 |
| 7 | TYRA | TYRA BIOSCIENCES INC | $22.2M | 3.68% | 695,315 | 增持 |
| 8 | WAY | WAYSTAR HLDG CORP | $19.0M | 3.15% | 925,834 | 减持 |
| 9 | SLS | SELLAS LIFE SCIENCES GROUP I | $18.2M | 3.01% | 1.2M | 新建仓 |
| 10 | IDYA | IDEAYA BIOSCIENCES INC | $17.9M | 2.96% | 480,383 | 新建仓 |
| 11 | ORKA | ORUKA THERAPEUTICS INC | $16.9M | 2.79% | 177,118 | 增持 |
| 12 | CI | THE CIGNA GROUP | $15.9M | 2.63% | 57,750 | 新建仓 |
| 13 | SNY | SANOFI SA | $15.5M | 2.57% | 364,200 | 增持 |
| 14 | ICLR | ICON PUB LTD CO | $15.3M | 2.53% | 88,186 | 减持 |
| 15 | VTRS | VIATRIS INC | $15.2M | 2.51% | 954,299 | 新建仓 |
| 16 | CCRN | CROSS CTRY HEALTHCARE INC | $14.5M | 2.40% | 1.1M | 持平 |
| 17 | RAPP | RAPPORT THERAPEUTICS INC | $12.8M | 2.12% | 307,657 | 减持 |
| 18 | ABT | ABBOTT LABORATORIES | $11.7M | 1.93% | 128,656 | 减持 |
| 19 | CELC | CELCUITY INC | $11.5M | 1.90% | 110,022 | 减持 |
| 20 | ZBH | ZIMMER BIOMET HOLDINGS INC | $11.3M | 1.87% | 131,445 | 增持 |
| 21 | REGN | REGENERON PHARMACEUTICALS | $11.2M | 1.86% | 18,000 | 新建仓 |
| 22 | BMY | BRISTOL-MYERS SQUIBB CO | $11.1M | 1.85% | 193,500 | 新建仓 |
| 23 | MDT | MEDTRONIC PLC | $11.1M | 1.84% | 142,500 | 新建仓 |
| 24 | VIR | VIR BIOTECHNOLOGY INC | $11.0M | 1.81% | 1.1M | 减持 |
| 25 | SENS | SENSEONICS HLDGS INC | $9.0M | 1.50% | 1.6M | 增持 |
来源：SEC 13F 申报文件 · 截至 2026-06-30
本期 13F-HR 中的全部持仓，以及相对上季度的变化。
13F 持仓，最新季度
来源SEC EDGAR13F-HR